Application of Nano Drugs in Treatment of Leishmaniasis
<p><strong>Objective:</strong> Leishmaniasis is endemic in 88 countries with incidence rate of 1.5-2 million; the most common form of leishmaniasis is cutaneous leishmaniasis (CL) with 1.5 million new cases per year. Correct diagnosis and characterization of the particular parasite...
Saved in:
Main Authors: | Seyed Hossein Shahcheraghi (Author), Jamshid Ayatollahi (Author), Marzieh Lotfi (Author), Ali Fattahi Bafghi (Author), Seyed Hossein Khaleghinejad (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2016-08-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiological Study an Outbreak of Cutaneous Leishmaniasis in Five Endemic Foci, Yazd Province, March 2015-March 2016.
by: Mohammad Hassan Lotfi, et al.
Published: (2017) -
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment
by: Darline B. dos Santos, et al.
Published: (2022) -
Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (SinaAmpholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
by: Seyed Ebrahim Eskandari, et al.
Published: (2018) -
Epidemiological Pattern of Cutaneous Leishmaniasis in the Province of Fars, Iran (Since 2010-2014)
by: Ali Fattahi Bafghi, et al.
Published: (2016) -
Isolation and Molecular Identification of Leishmania spp. in Patients With Cutaneous Leishmaniasis in Golestan Province, Iran
by: Ali Fattahi Bafghi, et al.
Published: (2019)